These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13887206)

  • 1. [On the simultaneous action of Cl. perfringens hemotoxin and B. proteus centrifugates in the presence of a specific anti-gangrene serum].
    DONETS IuI; DUMKINA NI
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Feb; 33():84-7. PubMed ID: 13887206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the specific inhibitory action of antiserums on L cultures of bacteria. II. The presence of H agglutinins in L antiserums].
    KIRN A; FLECK J; MINCK R
    Ann Inst Pasteur (Paris); 1962 Jan; 102():113-7. PubMed ID: 14456326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the specific inhibitory action of antisera on L cultures of bacteria. III. Localization of the H antigen by the immuno-fluorescence technic].
    FLECK J; MINCK R; KIRN A
    Ann Inst Pasteur (Paris); 1962 Feb; 102():243-6. PubMed ID: 13893458
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of aerobe mixed infection in gas gangrene. II. The behavior of the Welch-Fraenkel gas gangrene bacillus in aerobic mixed infections (in vivo)].
    Tarbiat S; Grün L
    Zentralbl Chir; 1967 Nov; 92(45):2805-10. PubMed ID: 4298966
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental study of gas gangrene mono- and trivaccines.
    DEMELOVA M; MALEK J; JOHANOVSKY J; HAZA J; BLASKO B; FRANCOVA D; MAZACEK M
    J Hyg Epidemiol Microbiol Immunol; 1961; 5():470-8. PubMed ID: 13885307
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the nature of the hemotoxin detected in a focus of the lesion and in the blood serum in experimental mixed infections caused by Cl. perfringens and oedematiens].
    MINERVIN SM; ZHAK SP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Sep; 33():127-32. PubMed ID: 14474307
    [No Abstract]   [Full Text] [Related]  

  • 7. [PREPARATION OF TYPE-SPECIFIC PRECIPITATING SERA FOR THE DIAGNOSIS OF CL. PERFRINGENS].
    VORONOVA ZA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():126-8. PubMed ID: 14077125
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the simultaneous activity of C. perfringens toxin and Proteus culture centrifugates in animal experiments].
    DONETS IuI
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Mar; 33():108-12. PubMed ID: 13887207
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental gas gangrene: the effect of antiserum on the growth of Clostridium welchii type A.
    BULLEN JJ; CUSHNIE GH
    J Pathol Bacteriol; 1962 Jul; 84():177-92. PubMed ID: 13874612
    [No Abstract]   [Full Text] [Related]  

  • 10. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN).
    EVANS DG; PERKINS FT
    Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of the various types of Cl. perfringens: remarks on anti-gangrene serums].
    GUILLAUMIE M; KREGUER A
    Rev Immunol Ther Antimicrob; 1951; 15(1-2):47-67. PubMed ID: 14865372
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-gangrene serums. Persistence of anti-septicum and anti-oedematiens immunity after the arrest of corresponding immunization].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    Rev Immunol Ther Antimicrob; 1960; 24():581-605. PubMed ID: 13709613
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental substantiation of the possibility to obtain anti-Proteus plasma].
    Nazarchuk LV; Zverkova AS; Koval' AI; Kubrachenko SIa; Fedorovs'ka OO
    Fiziol Zh (1978); 1992; 38(3):40-3. PubMed ID: 1499760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the effect of penicillin on hemotoxin production by Clostridium perfringens type A].
    MEISEL H; RYBICKA I; MEISEL P
    Med Dosw Mikrobiol; 1949; 1(4):556-78. PubMed ID: 14779873
    [No Abstract]   [Full Text] [Related]  

  • 15. ASSAY OF POTENCY OF THE PROPOSED FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS).
    PRIGGE R; MICKE H; KRUEGER J
    Bull World Health Organ; 1963; 29(6):737-43. PubMed ID: 14107746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of para-aminobenzoic acid and certain derivatives on Clostridium perfringens and on the hemotoxin in culture].
    MEISEL H; RYBICKA I; MEISEL P
    Med Dosw Mikrobiol; 1950; 2(2):242. PubMed ID: 14815346
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some properties of the O antigen of Proteus X-19].
    Siwecka M; Wojciechowski E
    Med Dosw Mikrobiol; 1967; 19(2):129-36. PubMed ID: 6081955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of synthomycin and levomycin alone or in combination with anti-gangrene serum in experimental gas infection produced by an association of microorganisms].
    SOLOV'EV SV; MATVEEV KI
    Eksp Khirurgiia; 1960; 5():62. PubMed ID: 13832691
    [No Abstract]   [Full Text] [Related]  

  • 19. [SORPTION OF ANTITOXIC ANTIGANGRENE SERUM WITH HUMAN ERYTHROCYTES].
    SINADSKII NE
    Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():121-3. PubMed ID: 14077123
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the production of gas gangrene serum in general and of polyvalent gas gangrene aphylacto-serum of the horse especially using the simultaneous immunization method with the 4 known gas gangrene types in uno].
    Becker M
    Arch Exp Veterinarmed; 1967; 21(2):519-46. PubMed ID: 4302817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.